Skip to main content
Equibles
ENSG logo

ENSG · Ensign Group, Inc · Metrics

Track ENSG — free

Use ENSG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENSG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$172.00 -3.53 (-2.01%) At close · Sep 30
Ex-dividend: $0.065 · Sep 30, 2026 Return incl. dividend (before tax) -1.97%
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.21B
Shares
58.28M
Volume · Sep 30 317.04K Avg daily vol (3M) 392.39K

ENSG metrics

92 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$172.00
Market cap
$10.21B

Price action

20 metrics
Price change (1W)
-0.4%
Price change (30D)
+1.9%
Price change (3M)
+9.5%
Price change (6M)
-12.9%
Price change (YTD)
+0.8%
Price change (1Y)
+2.3%
Trailing year
Price change (5Y)
+133.5%
52-week high
$215.83
52-week low
$147.13
Change from 52-week high
-18.7%
Change from 52-week low
+19.3%
Annualized volatility
27.8%
Annualized volatility (3M)
21.6%
Beta
0.0
RSI (14D)
51.1
Price vs SMA 50
-0.6%
Price vs SMA 200
-3.5%
Avg volume (3M)
400,879
Relative volume
0.8
Average dollar volume
$69.74M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
58.28M

Valuation

12 metrics
P / E (TTM)
27.5
Trailing earnings · reciprocal yield 3.6%
PEG ratio
1.7
EV / revenue
1.8×
reciprocal yield 54.7%
EV / EBITDA
17.2×
reciprocal yield 5.8%
EV / EBIT
21.5×
reciprocal yield 4.7%
P / sales
1.9×
reciprocal yield 53.7%
P / book
4.2
reciprocal yield 23.9%
FCF yield
—
TTM · current market cap
Buyback yield
0.4%
P / FCF
—
P / operating cash flow
16.8
reciprocal yield 6.0%
Earnings yield
3.7%

Historical valuation

8 metrics
P / E historical average (3Y)
29.0×
reciprocal yield 3.5%
P / E historical average (5Y)
26.8×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
1.8×
reciprocal yield 56.3%
EV / revenue historical average (5Y)
1.7×
reciprocal yield 58.1%
EV / EBIT historical average (3Y)
22.4×
reciprocal yield 4.5%
EV / EBIT historical average (5Y)
20.3×
reciprocal yield 4.9%
EV / EBITDA historical average (3Y)
17.9×
reciprocal yield 5.6%
EV / EBITDA historical average (5Y)
16.3×
reciprocal yield 6.1%

Dividends & buybacks

7 metrics
Dividend yield
0.0%
Trailing 12 months
Payout ratio
3.9%
Shareholder yield
0.5%
Dividend / share (TTM)
$0.07
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2026-09-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
20.7%
Operating margin
8.5%
Trailing 12 months
Net margin
6.9%
Gross profit (TTM)
—
Operating profit (TTM)
$467.39M
Net income (TTM)
$378.70M
Trailing 12 months
Diluted EPS (TTM)
$6.38
FCF margin
—
Effective tax rate
24.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$38.42

Growth

11 metrics
Revenue growth YoY
+17.3%
Year over year
Net income growth YoY
+18.2%
Revenue (TTM)
$5.49B
Trailing 12 months
EPS growth YoY
+16.7%
Shares change YoY
+1.5%
Year over year · more shares
Revenue CAGR (3Y)
+18.7%
Revenue CAGR (5Y)
+16.1%
EPS CAGR (3Y)
+13.9%
EPS CAGR (5Y)
+13.8%
FCF CAGR (3Y)
+145.2%
FCF CAGR (5Y)
+31.1%

Quality

14 metrics
Return on equity
15.5%
Return on assets
6.6%
Debt / equity
0.1
Current ratio
1.2
EBITDA (TTM)
$581.95M
Free cash flow (TTM)
—
Quick ratio
1.2
Interest coverage
60.0
Net debt / EBITDA
-0.3
Return on invested capital
15.7%
Trailing 12 months
Net cash
$181.10M
Latest balance sheet
Cash & equivalents
$262.30M
Total assets
$5.75B
Total debt
$139.74M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$608.43M
Capital expenditures (TTM)
$71.54M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$55.97M
R&D / revenue
—
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
556
13F filer change QoQ
-21
Institutional ownership
91.5%

Short interest

3 metrics
Short interest
2.6%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$152,697
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1125376 CUSIP 29358P101 13F (30d) 14 filings 14 filers Visit website Investor relations